SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-22-002015
Filing Date
2022-06-16
Accepted
2022-06-16 17:24:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422010_06162022.htm SC 13G 278446
2 JOINT FILING AGREEMENT ex991to13g07422010_06162022.htm EX-99.1 8370
  Complete submission text file 0000921895-22-002015.txt   288533
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Subject) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92588 | Film No.: 221021541
SIC: 2834 Pharmaceutical Preparations